共 279 条
- [41] Feldman PL(2012)The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation Am J Physiol 302 1379-undefined
- [42] Lambert MH(2012)PPARs at the crossroads of lipid signaling and inflammation Trends Endocrinol Metab 23 68-undefined
- [43] Henke BR(2014)Minireview: Challenges and opportunities in development of PPAR agonists Mol Endocrinol 28 undefined-undefined
- [44] Gervois P(2008)The PPAR?-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPAR? Toxicol Sci 101 undefined-undefined
- [45] Torra IP(2007)Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer Mol Cancer Ther 6 undefined-undefined
- [46] Chinetti G(2011)Peroxisome proliferator-activated receptors and cancer: challenges and opportunities Br J Pharmacol 164 undefined-undefined
- [47] Grötzinger T(undefined)undefined undefined undefined undefined-undefined
- [48] Dubois G(undefined)undefined undefined undefined undefined-undefined
- [49] Fruchart JC(undefined)undefined undefined undefined undefined-undefined
- [50] Fruchart-Najib J(undefined)undefined undefined undefined undefined-undefined